The prevalence of diabetic cardiomyopathy is gradually increasing each year,and it is currently the most common cause of death and disability in diabetic patients.It is characterized mainly by diastolic dysfunction and cardiac remodeling,slow progression,and a lack of obvious symptoms in the early stage,which makes early diagnosis difficult.Currently,the main techniques employed in the diagnosis of diabetic cardiomyopathy include imaging techniques such as echocardiography and magnetic resonance imaging,as well as biomarkers such as natriuretic peptide and brain natriuretic peptide.However,these techniques are short of specificity.This paper summarizes the research progress and current limitations of non-coding RNA as a potential biomarker with the aim of providing some clues for the early diagnosis of diabetic cardiomyopathy.
维普
万方数据